Smithwick EM - Search Results

1

Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.

Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, Smithwick EM, O'Malley J, Barandun S, Hilgartner MW. Bussel JB, et al. Among authors: smithwick em. Blood. 1983 Aug;62(2):480-6. Blood. 1983. PMID: 6191803 Free article.

2

Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease.

Cunningham-Rundles C, Siegal FP, Smithwick EM, Lion-Boulé A, Cunningham-Rundles S, O'Malley J, Barandun S, Good RA. Cunningham-Rundles C, et al. Among authors: smithwick em. Ann Intern Med. 1984 Oct;101(4):435-9. doi: 10.7326/0003-4819-101-4-435. Ann Intern Med. 1984. PMID: 6206756

3

Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease.

Cunningham-Rundles C, Smithwick EM, Siegal FP, Day NK, Lion A, O'Malley J, Barandun S, Good RA. Cunningham-Rundles C, et al. Among authors: smithwick em. Birth Defects Orig Artic Ser. 1983;19(3):201-3. Birth Defects Orig Artic Ser. 1983. PMID: 6197105 Clinical Trial. No abstract available.

4

High-dose intravenous gamma globulin for autoimmune neutropenia.

Pollack S, Cunningham-Rundles C, Smithwick EM, Barandun S, Good RA. Pollack S, et al. Among authors: smithwick em. N Engl J Med. 1982 Jul 22;307(4):253. doi: 10.1056/NEJM198207223070420. N Engl J Med. 1982. PMID: 6178028 No abstract available.

5

Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases.

Iwata T, Incefy GS, Cunningham-Rundles S, Cunningham-Rundles C, Smithwick E, Geller N, O'Reilly R, Good RA. Iwata T, et al. Am J Med. 1981 Sep;71(3):385-94. doi: 10.1016/0002-9343(81)90164-9. Am J Med. 1981. PMID: 7197118 No abstract available.

6

Impaired proliferative response to B-lymphocyte activators in common variable immunodeficiency.

Cunningham-Rundles S, Cunningham-Rundles C, Ma DI, Siegal FP, Gupta S, Smithwick EM, Kosloff C, Good RA. Cunningham-Rundles S, et al. Among authors: smithwick em. Scand J Immunol. 1982 Mar;15(3):279-86. doi: 10.1111/j.1365-3083.1982.tb00650.x. Scand J Immunol. 1982. PMID: 7046032

7

Defective cellular immune response in vitro in common variable immunodeficiency.

Cunningham-Rundles S, Cunningham-Rundles C, Siegal FP, Gupta S, Smithwick EM, Kosloff C, Good RA. Cunningham-Rundles S, et al. Among authors: smithwick em. J Clin Immunol. 1981 Jan;1(1):65-72. doi: 10.1007/BF00915478. J Clin Immunol. 1981. PMID: 7037826

8

Thymic activity in severe combined immunodeficiency diseases.

Incefy GS, Dardenne M, Pahwa S, Grimes E, Pahwa RN, Smithwick E, O'Reilly R, Good RA. Incefy GS, et al. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1250-3. doi: 10.1073/pnas.74.3.1250. Proc Natl Acad Sci U S A. 1977. PMID: 322151 Free PMC article.

9

Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases.

Incefy GS, Boumsell L, Kagan W, Goldstein G, Sousa MD, Smithwick E, O'Reilly R, Good RA. Incefy GS, et al. Trans Assoc Am Physicians. 1975;88:135-45. Trans Assoc Am Physicians. 1975. PMID: 772925 No abstract available.

10

Circulating thymic-hormone activity in congenital immunodeficiency.

Lewis V, Twomey JJ, Goldstein G, O'Reilly R, Smithwick E, Pahwa R, Pahwa S, Good RA, Schulte-Wisserman H, Horowitz S, Hong R, Jones J, Sieber O, Kirkpatrick C, Polmar S, Bealmear P. Lewis V, et al. Lancet. 1977 Sep 3;2(8036):471-5. doi: 10.1016/s0140-6736(77)91601-4. Lancet. 1977. PMID: 70687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters